Entry Point Capital, LLC Integra Lifesciences Holdings Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 5,812 shares of IART stock, worth $101,593. This represents 0.25% of its overall portfolio holdings.
Number of Shares
5,812
Previous 4,580
26.9%
Holding current value
$101,593
Previous $162 Million
4.31%
% of portfolio
0.25%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding IART
# of Institutions
255Shares Held
75.5MCall Options Held
10.7KPut Options Held
57.7K-
Black Rock Inc. New York, NY11.3MShares$197 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$136 Million0.0% of portfolio
-
Morgan Stanley New York, NY5.5MShares$96.1 Million0.01% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$73.7 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.89MShares$67.9 Million0.02% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $1.46B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...